Lauren Santye, Assistant Editor

Incidence of sleep apnea is 75% higher in patients with rheumatoid arthritis.

Gene may induce a broad-spectrum cellular response against infectious diseases.

RG-101 placed on clinical hold last year after a second reported case of jaundice.

Regulus Therapeutics treatment reduces HCV replication in the liver.

Top news of the day from across the health care landscape.

Recommendations for screening, diagnosis, management, and treatment for the specific forms are also included in the position paper.

In an investigation led by the Long Island drug diversion unit of the Drug Enforcement Administration (DEA), Troyan was found to be responsible for distributing more than 70,000 pills over the course of 4 years.

Risk factor may serve as a future drug target for ulcerative colitis.

Daniel P. Kus, BS Pharm, RPh, discusses how specialty pharmacies can help patients manage out-of-pocket drug spending.

Findings may lead to increased survival in patients with glioblastoma.

PHLDB3 inhibits the p53 protein to promote tumor growth.

Study estimates 27% of men avoided an unnecessary biopsy for prostate cancer when given an MRI scan first.

Top news of the day from across the health care landscape.

PGAM1 inhibitors sensitize tumors to lynparza (Olaparib) treatment.

Statins degrade mutated p53 proteins, offering future cancer treatment.

Poor long-term survival rates for pediatric patients with acute megakaryoblastic leukemia.

New index more precisely determines the probability of reducing liver fat during lifestyle interventions.

The microbiome and inflammatory signature differs in patients with type 1 diabetes.

Top news of the day from across the health care landscape.

Most of the Ebola-related deaths in West Africa could have been prevented, experts say.

Diabetes-related outcomes significantly differ by state and insurance type.

The new test service helps physicians assess patient’s responses to antiretroviral therapy for HBV.

Cancer cells learn to cope with large scale DNA changes.

Top news of the day from across the health care landscape.

Specialty marketplace continues to thrive going forward.

Severe adverse events may be associated with new class of hepatitis C medications.

Methotrexate and cyclophosphamide burn excessive dietary fat.

Newly-approved nusinersen does not completely treat the muscular disorder.

Aurintricarboxylic acid blocks the spread of glioblastoma.

Top news of the day from across the health care landscape.